Editorial p115 The value of patient experience in multiple sclerosis research The Lancet Neurology ++ +... +...

A multimodal individualized long-term intervention to prevent functional decline after stroke (LAST-long): a single blinded randomised controlled trial Torunn Askima,b,j torunn.askim@ntnu.no ∙ Sara Rise Langloa,c,j ∙ Elin Bergha,d ∙ Øystein Døhla,e ∙ Hanne Ellekjæra,b ∙ Anne Hokstada,c ∙ et al. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00323-0/fulltext?dgcid=hubspot_email_infocusalerts-neurology_feature&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-9Hjh-_IXvEs33uN42o80pFeEkEGgQ7db8b5mSk-CU5WrUizkGjKzWzDiIdZhQhOWrax7wg30dPSQNmOJZ0YMHNRqFbug&_hsmi=404745008&utm_content=404691632&utm_source=hs_email Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial Prof Tom Solomon, FMedSci, PhDa,b,c,d tsolomon@liverpool.ac.uk ∙ Cory Hooper, PhDd ∙ Ava Easton, PhDd,e ∙ Anna Rosala-Hallas, MScf ∙ Bethany Facer, MScg ∙ Perry Moore, PhDc ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00454-5/fulltext?dgcid=hubspot_email_infocusalerts-neurology_feature&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-_KFnSEeh3zG2AYRY-WA_FU6yYDc8wxk38NS-V1eWa0KCw9psaUQ6Qx93K1rijACkNPstHvXWu8AHb2ePmX9dIwcIVTsA&_hsmi=404745008&utm_content=404691632&utm_source=hs_email Editorial p115 The value of patient experience in multiple sclerosis research The Lancet Neurology https://www.thelancet.com/journals/laneur/issue/vol25no2/PIIS1474-4422(26)X0002-3 Editorial A new path for assisted dying in Europe: France's middle way The Lancet Regional Health – Europe https://www.thelancet.com/journals/lanepe/issue/vol61nonull/PIIS2666-7762(25)X0012-0